32 55

Cited 0 times in

Heart Failure Statistics in Korea, 2020: A Report from the Korean Society of Heart Failure

Authors
 Jin Joo Park  ;  Chan Joo Lee  ;  Sung-Ji Park  ;  Jin-Oh Choi  ;  Seonghoon Choi  ;  Seong-Mi Park  ;  Eui Young Choi  ;  Eung Ju Kim  ;  Byung-Su Yoo  ;  Seok-Min Kang  ;  Myung Hee Park  ;  Jungkuk Lee  ;  Dong-Ju Choi 
Citation
 International Journal of Heart Failure, Vol.3(4) : 224-236, 2021-10 
Journal Title
International Journal of Heart Failure
ISSN
 2636-154X 
Issue Date
2021-10
Keywords
Heart failure ; Epidemiology ; Statistics ; Korea
Abstract
Background and Objectives
Heart failure (HF) is a disease with high morbidity and mortality. With ageing society and increasing prevalence of risk factors of HF, the prevalence of HF is expected to increase, as well. In this official report of the Korean Society of Heart Failure the epidemiology of HF in Korea is presented.

Methods
The data of Korean National Health Insurance big data, the Korean Heart Failure (KorHF) and the Korean Acute Heart Failure (KorAHF) registries have been used.

Results
In 2018, the prevalence, incidence, mortality of HF patients, and mortality due to HF were 2,261, 579, 245, and 10.4 per 100.000 persons, respectively. Regarding the temporal trend, there was a continuous increase in HF prevalence (0.77% in 2002, 1.48% in 2013, and 2.24% in 2018) and HF related deaths. The most common etiology for HF was ischemic origin, and the dominant subtype was HF with reduced ejection fraction (EF), defined as EF ≤40%. Of these, 77.6%, 58.0%, and 55.1% received renin-angiotensin-system inhibitors (angiotensin-converting-enzyme inhibitors or angiotensin-receptor-blockers), beta-blockers, and aldosterone-antagonists, respectively. In 2018, 1,542 implantable cardiac defibrillators and 272 cardiac resynchronization therapy devices were implanted, and 176 patients received heart transplantation. With improvement of pharmacologic and non-pharmacological therapy, the survival time of HF has been improving in the last 2 decades; nonetheless, it is associated with enormous increase in medical costs.

Conclusions
The prevalence of HF has been increasing in Korea. With improvement of therapy, the prognosis of HF has been improving, too. Nonetheless, appropriate interventions are necessary to prevent HF.
Files in This Item:
T202125323.pdf Download
DOI
10.36628/ijhf.2021.0023
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Seok Min(강석민) ORCID logo https://orcid.org/0000-0001-9856-9227
Lee, Chan Joo(이찬주) ORCID logo https://orcid.org/0000-0002-8756-409X
Choi, Eui Young(최의영) ORCID logo https://orcid.org/0000-0003-3732-0190
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187798
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links